Pioneering a Sustainable and Effective Future in Neurorehabilitation
Redefining Post-Stroke Treatment with Safe, Sustainable, and Effective Solutions
Discover more
About NEUROBITE
NEUROBITE Technologies is a spin-out from the University of Glasgow. We are developing biodegradable implantable medical devices to treat neurological conditions such as stroke and Parkinson’s Disease. Our focus is to transform stroke recovery through groundbreaking technologies, aiming to reduce the need for invasive surgeries and to offer more sustainable treatment options.
Why This Matters:
- Growing Market: The stroke care market is a rapidly growing sector. With over 1 million strokes per year in Europe alone, the need for innovative solutions is growing exponentially.
- Scalable Technology: The potential to scale our biodegradable devices extends beyond stroke to other neurological conditions such as Parkinson’s and brain injuries.
Speak to our team
The Challenges in Post-Stroke Treatment
Stroke recovery is often a difficult and uncertain journey. Millions of people face this every year. Despite the number of options available, many post-stroke treatments are either inadequate, invasive, or high-risk.
Limited Treatment Options
Conventional stroke rehabilitation methods can be insufficient and lack personalisation.
Surgical Concerns
The risk of complications from multiple surgeries is significant.
Environmental Impact
Traditional devices contribute to increasing medical waste, adding pressure to an already burdened healthcare system.
Together, We Can Improve Stroke Treatment.
Get Involved
Our Solution
Biodegradable Neural Probes
Introducing BITE (Brain Implantable Transient Electronics) probes – biodegradable neural probes designed to stimulate brain regions affected by stroke and other neurological conditions. This technology significantly reduces the need for invasive surgeries and improves the rehabilitation process by stimulating brain regions and promoting new neural connections.
Get in Touch
Opportunity
Why Invest in NEUROBITE?
High Impact
Targeting the global stroke care market, which costs the EU alone €45 billion annually.
Sustainability Edge
Our biodegradable approach positions us at the forefront of a new era in healthcare that addresses both patient needs and environmental concerns.
Market Growth
The neurotech market is projected to grow at a CAGR of X%, with an increasing demand for non-invasive solutions.
Meet The Innovators Behind NEUROBITE
Maria Cerezo Sanchez
CEO and Co-FounderÂ
Hadi Heidari
Co-founder and Chief Scientific Advisor
Danial Kiamarsi
Clinical Scientist
Angel Canal-Alonso
Machine Learning and Data Scientist
News & Updates
Get Involved
We’re looking for investors, collaborators, and partners who are as excited about our vision as we are. Join us in shaping the future of stroke treatment and make an impact on millions of lives.